Table 3.
Changes in imaging before and after sodium nitroprusside
Patient | TCD cm/s mean | CTA/CTP prior to SNP | Antihypertensive after SNP | SNP dose | DSA post-SNP |
---|---|---|---|---|---|
1 | MCA L 290, ACA L stump | Mean transit time + time to peak prolonged in left MCA/ACA prolonged, no infarction | 150 mg Urapidil | 3 × 7 mg | Punctual stenosis in the left MCA (80%) and ACA 85%, ICA 60%, no remaining perfusion disturbance |
2 | MCA L 290, MCA R filiform, bilateral stump in the ACA | Massive prolongation of mean transit time + time to peak bifrontal, massive vasospasm with narrowing the MCA and the ACA about 95% |
100 mg Propofol 300 mg Urapidil |
3 × 6 + 8 + 10 mg and high-dose Molsidomine | MCA 30% narrowing, ACA R punctual 90%, ACA L 50% narrowing no new perfusion arrest |
3 | NA | Both MCA narrowing 70%, mean transit time + time to peak prolonged, CBF reduced in left MCA/ACA territories, no infarction |
40 mg Urapidil 250 mg Propofol |
2 × 5 mg + 7 mg SNP | No constriction > 50%, no perfusion disorder |
These examples illustrate the relationship between transcranial Doppler ultrasonography and CT diagnostics (CT perfusion and CT angiography) before sodium nitroprusside application, the amount of antihypertensives required after sodium nitroprusside application to control evoked systemic hypertension and the subsequent alleviation of vasospasm on digital subtraction arteriography
2: After unintended Molsidomine interruption
ACA anterior cerebral artery, CTA CT angiography, CTP CT perfusion, DSA digital substraction angiography, MCA middle cerebral artery, NA not applicable, SNP sodium nitro prusside, TCD transcranial doppler sonography